Deliver to United Kingdom
0

HPLC column NUCLEODUR ® Phenyl-Hexyl, 5 µm, 125 mm, 4 mm

£ 628.88*

*Prices plus VAT plus shipping costs

£ 754.66*

*incl. VAT, plus shipping costs

HPLC column NUCLEODUR ® Phenyl-Hexyl, 5 µm, 125 mm, 4 mm

Order number: 34P6.1

Part number: AC100008374

Out of Stock

Price Breakdown

1

6

24

Suitable for laboratory and industrial environments, the HPLC column NUCLEODUR ® Phenyl-Hexyl offers exceptional performance for separating aromatic and unsaturated compounds, antibiotics, pharmaceutical products, steroids, and even those suitable for LC-MS applications. Featuring fully porous particles (FPP), this reversed phase (RP) column boasts a particle size of 5 μm, a specific surface area of 340 m²/g, and a pore size of 110 Å. Its unique phenylhexyl modification ensures π-π and hydrophobic interactions, making it ideal for polar compounds. With a pressure stability of up to 600 bar and temperature stability at 60°C, this analytical separation column delivers reliable results under various conditions.

  • Category: Separation columns for HPLC
  • Surface chemistry: Phenylhexyl modification
  • Column volume: 1.56 ml
  • Eluent in column: Acetonitrile - Water
  • Recommended application(s): Antibiotics Aromatic and unsaturated compounds Suitable for LC-MS Pharmaceutical products Especially for polar compounds Steroids
  • L x Ø internal (column): 125 x 4 mm
  • USP listing: L11
  • Pressure stability: 600 bar
  • Temperature stability: 60 ° C
  • Separation principle: Reversed phase (RP)
  • Interactions / retention mechanism: π-π and hydrophobic
  • Particle size: 5 µm
  • Column shape: Analytical separation column
  • Specific surface according to BET: 340 m²/g
  • Pore volume: 0.9 ml/g
  • Endcapped: yes
  • Application Database (Macherey-Nagel): HPLC
  • Column type: HPLC column
  • Pore size: 110 Å
  • Phase: Phenyl-Hexyl
  • pH stability: 1,0-10,0
  • Particle type: Fully porous particles (FPP)
allied chemi
  • secure-payment
  • visa
  • american-express
  • master-card

© 2026 Copyright. All Rights Reserved.